Moreover, M2-type TAMs also exhibit a high degree of expression of the inhibitory receptors PD-1 and CTLA-4, further creating an inflammatory immunosuppressive microenvironment in HCC (87). The gene discussed is CTLA4; the disease is hepatocellular carcinoma.